Teva Pharmaceutical Industries reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy. CEO Richard Francis speaks with Bloomberg's Scarlet Fu and Katie Griefeld.

Siemens CEO Roland Busch Talks AI
07:15

Former SEC Chair Gary Gensler Talks AI Hype, IPO Outlook
13:20

Former NY Fed President Bill Dudley Talks Alan Greenspan, Warsh
08:37